209 related articles for article (PubMed ID: 22922523)
1. Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation.
Srinivasan A; Wang C; Srivastava DK; Burnette K; Shenep JL; Leung W; Hayden RT
Biol Blood Marrow Transplant; 2013 Jan; 19(1):94-101. PubMed ID: 22922523
[TBL] [Abstract][Full Text] [Related]
2. Infections diagnosed in the first year after pediatric stem cell transplantation.
Benjamin DK; Miller WC; Bayliff S; Martel L; Alexander KA; Martin PL
Pediatr Infect Dis J; 2002 Mar; 21(3):227-34. PubMed ID: 12005087
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
4. Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience.
Srinivasan A; McLaughlin L; Wang C; Srivastava DK; Shook DR; Leung W; Hayden RT
Transpl Infect Dis; 2014 Feb; 16(1):90-7. PubMed ID: 24256514
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study.
Styczynski J; Czyzewski K; Wysocki M; Gryniewicz-Kwiatkowska O; Kolodziejczyk-Gietka A; Salamonowicz M; Hutnik L; Zajac-Spychala O; Zaucha-Prazmo A; Chelmecka-Wiktorczyk L; Siewiera K; Fraczkiewicz J; Malas Z; Tomaszewska R; Irga-Jaworska N; Plonowski M; Ociepa T; Pierlejewski F; Gamrot Z; Urbanek-Dadela A; Gozdzik J; Stolpa W; Dembowska-Baginska B; Perek D; Matysiak M; Wachowiak J; Kowalczyk J; Balwierz W; Kalwak K; Chybicka A; Badowska W; Szczepanski T; Drozynska E; Krawczuk-Rybak M; Urasinski T; Mlynarski W; Woszczyk M; Karolczyk G; Sobol-Milejska G; Gil L;
Clin Microbiol Infect; 2016 Feb; 22(2):179.e1-179.e10. PubMed ID: 26493843
[TBL] [Abstract][Full Text] [Related]
6. A review of infectious complications after haploidentical hematopoietic stem cell transplantations.
Atilla E; Atilla PA; Bozdağ SC; Demirer T
Infection; 2017 Aug; 45(4):403-411. PubMed ID: 28417421
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP.
Pichler H; Lawitschka A; Glogova E; Willasch AM; von Luettichau I; Lehrnbecher T; Matthes-Martin S; Lang P; Bader P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Kuhlen M; Meisel R; Guengoer T; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Peters C
Am J Hematol; 2019 Aug; 94(8):880-890. PubMed ID: 31095771
[TBL] [Abstract][Full Text] [Related]
8. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
9. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.
Düver F; Weißbrich B; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
PLoS One; 2020; 15(2):e0228451. PubMed ID: 32017805
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Infectious Complications in Children With Acute Lymphoblastic Leukemia Treated With Hematopoietic Stem Cell Transplantation.
Zaucha-Prażmo A; Kowalczyk JR; Drabko K; Czyżewski K; Goździk J; Zając-Spychała O; Wachowiak J; Frączkiewicz J; Gorczyńska E; Kałwak K; Styczyński J
Transplant Proc; 2017 Nov; 49(9):2183-2187. PubMed ID: 29149980
[TBL] [Abstract][Full Text] [Related]
11. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study.
Junghanss C; Marr KA; Carter RA; Sandmaier BM; Maris MB; Maloney DG; Chauncey T; McSweeney PA; Storb R
Biol Blood Marrow Transplant; 2002; 8(9):512-20. PubMed ID: 12374456
[TBL] [Abstract][Full Text] [Related]
12. Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.
Crocchiolo R; Bramanti S; Vai A; Sarina B; Mineri R; Casari E; Tordato F; Mauro E; Timofeeva I; Lugli E; Mavilio D; Carlo-Stella C; Santoro A; Castagna L
Transpl Infect Dis; 2015 Apr; 17(2):242-9. PubMed ID: 25648539
[TBL] [Abstract][Full Text] [Related]
13. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
14. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.
Marr KA; Carter RA; Boeckh M; Martin P; Corey L
Blood; 2002 Dec; 100(13):4358-66. PubMed ID: 12393425
[TBL] [Abstract][Full Text] [Related]
15. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
[TBL] [Abstract][Full Text] [Related]
16. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
[TBL] [Abstract][Full Text] [Related]
17. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
[TBL] [Abstract][Full Text] [Related]
18. The impact of alternative donor types on viral infections in pediatric hematopoietic stem cell transplantation.
Atay D; Akcay A; Erbey F; Ozturk G
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29297965
[TBL] [Abstract][Full Text] [Related]
19. Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy.
Behrendt CE; Rosenthal J; Bolotin E; Nakamura R; Zaia J; Forman SJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1):54-60. PubMed ID: 19135943
[TBL] [Abstract][Full Text] [Related]
20. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]